{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:09:05Z","timestamp":1788588545660,"version":"build-2803163510"},"reference-count":61,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015769","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T11:49:55Z","timestamp":1678794595000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Therapeutics for treating mpox in humans"],"prefix":"10.1002","volume":"2023","author":[{"given":"Tilly","family":"Fox","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences; Liverpool School of Tropical Medicine; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Gould","sequence":"additional","affiliation":[{"name":"Royal Liverpool University Hospital; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveena","family":"Princy","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases; Christian Medical College Vellore; Vellore India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Rowland","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences; Liverpool School of Tropical Medicine; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Lutje","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences; Liverpool School of Tropical Medicine; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Kuehn","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences; Liverpool School of Tropical Medicine; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"key":"10.1002\/14651858.CD015769-BIB0001|cit1","unstructured":"Expanded access protocol for the use of tecovirimat for the treatment of monkeypox infection www.isrctn.com\/ISRCTN43307947"},{"key":"10.1002\/14651858.CD015769-BIB0002|cit2","unstructured":"A multicenter, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox rctportal.niph.go.jp\/en\/detail?trial_id=jRCTs031220169"},{"key":"10.1002\/14651858.CD015769-BIB0003|cit3","unstructured":"Antiviral treatment with tecovirimat for patients managed at home with monkeypox (PLATINUM) isrctn.com\/ISRCTN17461766"},{"key":"10.1002\/14651858.CD015769-BIB0004|cit4","unstructured":"Tecovirimat in non-hospitalized patients with monkeypox (PLATINUM-CAN) clinicaltrials.gov\/ct2\/show\/NCT05534165"},{"key":"10.1002\/14651858.CD015769-BIB0005|cit5","unstructured":"Study of tecovirimat for human monkeypox virus (STOMP) clinicaltrials.gov\/ct2\/show\/NCT05534984"},{"key":"10.1002\/14651858.CD015769-BIB0006|cit6","unstructured":"Tecovirimat for treatment of monkeypox virus (PALM 007) clinicaltrials.gov\/ct2\/show\/NCT05559099"},{"key":"10.1002\/14651858.CD015769-BIB0007|cit7","unstructured":"Assessment of the efficacy and safety of tecovirimat in patients with monkeypox virus disease (UNITY) clinicaltrials.gov\/ct2\/show\/NCT05597735"},{"issue":"8","key":"10.1002\/14651858.CD015769-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD015769-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"106943","DOI":"10.1016\/j.ijsu.2022.106943","article-title":"The impact of monkeypox outbreak on mental health and counteracting strategies: a call to action","volume":"106","author":"Ahmed","year":"2022","journal-title":"International Journal of Surgery"},{"issue":"6","key":"10.1002\/14651858.CD015769-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD015769-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"12.01.518711","DOI":"10.1101\/2022.12.01.518711","article-title":"Virulence differences of monkeypox virus clades 1, 2a and 2b.1 in a small animal model","volume":"Preprint","author":"Americo","year":"2022","journal-title":"bioRxiv"},{"issue":"12","key":"10.1002\/14651858.CD015769-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.3390\/v2122803","article-title":"Cidofovir activity against poxvirus infections","volume":"2","author":"Andrei","year":"2010","journal-title":"Viruses"},{"issue":"10","key":"10.1002\/14651858.CD015769-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"e0007791","DOI":"10.1371\/journal.pntd.0007791","article-title":"A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy","volume":"13","author":"Beer","year":"2019","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"10.1002\/14651858.CD015769-BIB0014|cit14","unstructured":"Highlights of prescribing information Vaccinia Immune Globulin Intravenous (Human) www.fda.gov\/media\/77004\/download"},{"key":"10.1002\/14651858.CD015769-BIB0015|cit15","unstructured":"Centers for Disease Control and Prevention Monkeypox outbreak global map www.cdc.gov\/poxvirus\/monkeypox\/response\/2022\/world-map.html"},{"key":"10.1002\/14651858.CD015769-BIB0016|cit16","unstructured":"Centers for Disease Control and Prevention Treatment information for healthcare professionals. Updated 31 October 2022. Interim clinical guidance for the treatment of monkeypox www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/treatment.html"},{"key":"10.1002\/14651858.CD015769-BIB0017|cit17","unstructured":"Centers for Disease Control and Prevention Science brief: detection and transmission of mpox (formerly monkeypox) virus during the 2022 Clade IIb outbreak www.cdc.gov\/poxvirus\/monkeypox\/about\/science-behind-transmission"},{"key":"10.1002\/14651858.CD015769-BIB0018|cit18","unstructured":"Centers for Disease Control and Prevention Clinician FAQs www.cdc.gov\/poxvirus\/mpox\/clinicians\/faq.html"},{"key":"10.1002\/14651858.CD015769-BIB0019|cit19","unstructured":"TEMBEXA Highlights of prescribing information www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/214460s000,214461s000lbl.pdf"},{"key":"10.1002\/14651858.CD015769-BIB0020|cit20","unstructured":"Cochrane Risk of bias 2 tool www.riskofbias.info\/welcome\/rob-2-0-tool\/current-version-of-rob-2"},{"issue":"1","key":"10.1002\/14651858.CD015769-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(02)00008-6","article-title":"Cidofovir in the treatment of poxvirus infections","volume":"55","author":"De Clerq","year":"2002","journal-title":"Antiviral Research"},{"issue":"6","key":"10.1002\/14651858.CD015769-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: drug-induced liver injury","volume":"70","author":"European Association for the Study of the Liver","year":"2019","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD015769-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"e0005809","DOI":"10.1371\/journal.pntd.0005809","article-title":"Characterization of Monkeypox virus infection in African rope squirrels (Funisciurus sp.)","volume":"11","author":"Falendysz","year":"2017","journal-title":"PLOS Neglected Tropical Diseases"},{"issue":"11","key":"10.1002\/14651858.CD015769-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/v9110320","article-title":"The role of brincidofovir in preparation for a potential smallpox outbreak","volume":"9","author":"Foster","year":"2017","journal-title":"Viruses"},{"key":"10.1002\/14651858.CD015769-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"07.19.500484","DOI":"10.1101\/2022.07.19.500484","article-title":"Tecovirimat is highly efficient on the Monkeypox virus lineage responsible for the international 2022 outbreak","volume":"Pre-print","author":"Frenois-Veyrat","year":"2022","journal-title":"bioRxiv"},{"key":"10.1002\/14651858.CD015769-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"i3507","DOI":"10.1136\/bmj.i3507","article-title":"When and how to update systematic reviews: consensus and checklist","volume":"354","author":"Garner","year":"2016","journal-title":"BMJ"},{"issue":"9","key":"10.1002\/14651858.CD015769-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S1473-3099(22)00411-X","article-title":"Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis","volume":"22","author":"Girometti","year":"2022","journal-title":"Lancet Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD015769-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1705688","article-title":"Oral tecovirimat for the treatment of smallpox","volume":"379","author":"Grosenbach","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD015769-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.antiviral.2017.04.002","article-title":"Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand white rabbits","volume":"143","author":"Grossi","year":"2017","journal-title":"Antiviral Research"},{"key":"10.1002\/14651858.CD015769-BIB0030|cit30","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook"},{"issue":"13","key":"10.1002\/14651858.CD015769-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s40265-018-0967-6","article-title":"Tecovirimat: first global approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"issue":"1","key":"10.1002\/14651858.CD015769-BIB0032|cit32","first-page":"e00927","article-title":"Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model","volume":"6","author":"Hutson","year":"2021","journal-title":"mSphere"},{"issue":"5","key":"10.1002\/14651858.CD015769-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/AAC.01596-08","article-title":"ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification","volume":"53","author":"Jordan","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD015769-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-3542(02)00198-5","article-title":"In vitro activity of potential anti-poxvirus agents","volume":"57","author":"Kern","year":"2003","journal-title":"Antiviral Research"},{"issue":"2","key":"10.1002\/14651858.CD015769-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jiac.2022.10.009","article-title":"Lack of clinical evidence of antiviral therapy for human monkeypox: a scoping review","volume":"29","author":"Kuroda","year":"2023","journal-title":"Journal of Infection and Chemotherapy"},{"key":"10.1002\/14651858.CD015769-BIB0036|cit36","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases LiverTox: clinical and research information on drug-induced liver injury Available from www.ncbi.nlm.nih.gov\/books\/NBK585270\/"},{"issue":"5","key":"10.1002\/14651858.CD015769-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1099\/jgv.0.000422","article-title":"New effective chemically synthesized anti-smallpox compound NIOCH-14","volume":"97","author":"Mazurkov","year":"2016","journal-title":"Journal of General Virology"},{"key":"10.1002\/14651858.CD015769-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"2022.08.24.2227","DOI":"10.1101\/2022.08.24.22279177","article-title":"Monkeypox treatment with tecovirimat in the Central African Republic under an Expanded Access Programme","volume":"Pre-print","author":"Mbrenga","year":"2022","journal-title":"medRxiv"},{"key":"10.1002\/14651858.CD015769-BIB0039|cit39","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 6.3 (updated February 2022) Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015769-BIB0040|cit40","unstructured":"NHS Medway FOI 5839 response www.medway.nhs.uk\/downloads\/FOI%205839%20Response.pdf"},{"key":"10.1002\/14651858.CD015769-BIB0041|cit41","unstructured":"Public Health Scotland Mpox (monkeypox) www.nhsinform.scot\/illnesses-and-conditions\/infections-and-poisoning\/mpox-monkeypox\/"},{"key":"10.1002\/14651858.CD015769-BIB0042|cit42","unstructured":"National Institute of Allergy and Infectious Diseases Mpox (formerly monkeypox) treatment www.niaid.nih.gov\/diseases-conditions\/mpox-treatment"},{"issue":"37","key":"10.1002\/14651858.CD015769-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.15585\/mmwr.mm7137e1","article-title":"Clinical use of Tecovirimat (Tpoxx) for treatment of monkeypox under an investigational new drug protocol \u2014 United States, May-August 2022","volume":"71","author":"O\u2019Laughlin","year":"2022","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"10.1002\/14651858.CD015769-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijregi.2022.04.004","article-title":"A case of suicide during the 2017 monkeypox outbreak in Nigeria","volume":"3","author":"Ogoina","year":"2022","journal-title":"IJID Regions"},{"key":"10.1002\/14651858.CD015769-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"e072410","DOI":"10.1136\/bmj-2022-072410","article-title":"Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series","volume":"378","author":"Patel","year":"2022","journal-title":"BMJ"},{"issue":"37","key":"10.1002\/14651858.CD015769-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"16262","DOI":"10.1073\/pnas.1005769107","article-title":"Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo","volume":"107","author":"Rimoin","year":"2010","journal-title":"PNAS"},{"issue":"4","key":"10.1002\/14651858.CD015769-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4269\/ajtmh.2007.76.768","article-title":"Efficacy of the antipoxvirus compound ST-246 for treatment of severe orthopoxvirus infection","volume":"76","author":"Sbrana","year":"2007","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD015769-BIB0048|cit48","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015769-BIB0049|cit49","first-page":"109","article-title":"Broad spectrum antiviral nucleosides\u2014our best hope for the future","volume":"57","author":"Seley-Radtke","year":"2021","journal-title":"Elsevier Public Health Emergency Collection"},{"issue":"7","key":"10.1002\/14651858.CD015769-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1128\/AAC.49.7.2634-2641.2005","article-title":"Biological activity of an intravenous preparation of human vaccinia immune globulin in mouse models of vaccinia virus infection","volume":"49","author":"Shearer","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD015769-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/cid\/ciac622","article-title":"Antivirals with activity against mpox: a clinically oriented review","volume":"76","author":"Siegrist","year":"2023","journal-title":"Clinical Infectious Diseases"},{"issue":"17","key":"10.1002\/14651858.CD015769-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1128\/JVI.02173-10","article-title":"Effective antiviral treatment of systemic orthopoxvirus disease: ST-246 treatment of prairie dogs infected with monkeypox virus","volume":"85","author":"Smith","year":"2011","journal-title":"Journal of Virology"},{"key":"10.1002\/14651858.CD015769-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015769-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.antiviral.2015.02.007","article-title":"The efficacy and pharmacokinetics of brincidofovir for the treatment of lethal rabbitpox virus infection: a model of smallpox disease","volume":"117","author":"Trost","year":"2015","journal-title":"Antiviral Research"},{"key":"10.1002\/14651858.CD015769-BIB0055|cit55","unstructured":"World Health Organization Monkeypox: experts give virus variants new names www.who.int\/news\/item\/12-08-2022-monkeypox--experts-give-virus-variants-new-names"},{"key":"10.1002\/14651858.CD015769-BIB0056|cit56","unstructured":"World Health Organization WHO Director-General declares the ongoing monkeypox outbreak a Public Health Emergency of International Concern www.who.int\/europe\/news\/item\/23-07-2022-who-director-general-declares-the-ongoing-monkeypox-outbreak-a-public-health-event-of-international-concern"},{"key":"10.1002\/14651858.CD015769-BIB0057|cit57","unstructured":"World Health Organization Monkeypox factsheet www.who.int\/news-room\/fact-sheets\/detail\/monkeypox"},{"key":"10.1002\/14651858.CD015769-BIB0058|cit58","unstructured":"World Health Organization Fourth meeting of the International Health Regulations (2005) (IHR) Emergency Committee on the multi-country outbreak of monkeypox (mpox) who.int\/news\/item\/15-02-2023-fourth-meeting-of-the-international-health-regulations-(2005)-(ihr)-emergency-committee-on-the-multi-country-outbreak-of-monkeypox-(mpox)"},{"issue":"3","key":"10.1002\/14651858.CD015769-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijid.2005.12.001","article-title":"Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy","volume":"10","author":"Wittek","year":"2006","journal-title":"International Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD015769-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.31646\/gbio.12","article-title":"Efficacy of three key antiviral drugs used to treat orthopoxvirus infections: a systematic review","volume":"1","author":"Yu","year":"2022","journal-title":"Global Biosecurity"},{"key":"10.1002\/14651858.CD015769-BIB0061|cit61","doi-asserted-by":"crossref","unstructured":"Fox T Gould S Princy N Rowland T Kuehn R Therapeutics for treating mpox in humans. PROSPERO 2022. CRD42022382675 www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=382675","DOI":"10.1002\/14651858.CD015769"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T10:14:39Z","timestamp":1748340879000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015769"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015769","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,14]]}}}